656 Results

People

  1. Vickers
    Vickers
  2. Saltz
    Saltz
  3. Hudis
    Hudis
  4. Motzer
    Motzer
  5. Mao
    Mao
  6. Strong
    Strong
  7. Giralt
    Giralt
  8. Herr
    Herr
  9. Lee
    Lee
  10. Postow
    Postow

Groups

  1. Department of Medicine (293)
  2. Solid Tumor Oncology Division (193)
  3. Surgery (171)
  4. Survivorship Research (103)
  5. Population Sciences Research Program (99)
  6. Hematologic Malignancies, Division of (74)
  7. Epidemiology and Biostatistics (61)
  8. Center for Hematologic Malignancies (56)
  9. Gastrointestinal Oncology Service (52)
  10. Radiation Oncology, Department of (52)
  1. "randomized controlled trial (topic)"
Formats
  1. Journal Article (482)
  2. Review (85)
  3. Editorial (51)
  4. Correspondence (19)
  5. Guidelines (11)
  6. Research Letter (6)
  7. Conference Paper (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (293)
  2. Solid Tumor Oncology Division (193)
  3. Surgery (171)
  4. Survivorship Research (103)
  5. Population Sciences Research Program (99)
  6. Hematologic Malignancies, Division of (74)

More Groups

People
  1. Andrew Vickers (19)
  2. Leonard Saltz (18)
  3. Clifford Hudis (13)
  4. Robert Motzer (12)
  5. Jun Mao (11)
  6. Vivian Strong (10)

More People

Years
  1. 2025 (34)
  2. 2024 (75)
  3. 2023 (48)
  4. 2022 (47)
  5. 2021 (28)
  6. 2020 (30)

More Years

Publications
  1. Journal of Clinical Oncology (44)
  2. Journal of the National Comprehensive Cancer Network (33)
  3. European Urology (30)
  4. Annals of Surgical Oncology (18)
  5. International Journal of Radiation Oncology, Biology, Physics (12)
  6. Lancet Oncology (12)

More Publications

Publishers
  1. Elsevier Inc. (100)
  2. Elsevier Science, Inc. (70)
  3. Springer (50)
  4. American Society of Clinical Oncology (48)
  5. Oxford University Press (36)
  6. Lippincott Williams & Wilkins (34)

More Publishers

Results (656)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Systematic review of stereotactic ablative radiotherapy (SABR)/stereotactic body radiation therapy (SBRT) for treatment of high-risk patients with stage I non-small cell lung cancer
    Review

    Wolf, A.; Loo, B. W. Jr; Mak, R. H.; Liptay, M.; Pettiford, B.; Rocco, G.; Lanuti, M.; Merritt, R. E.; Keshavarz, H.; Suh, R. D.; more...
    Seminars in Thoracic and Cardiovascular Surgery (2025)

    Fulltext@MSK | Save
  • Systematic review of sublobar resection for treatment of high-risk patients with stage I non-small cell lung cancer
    Review

    Merritt, R. E.; Brunelli, A.; Walsh, G.; Murthy, S.; Schuchert, M. J.; Varghese, T. K. Jr; Lanuti, M.; Wolf, A.; Keshavarz, H.; Loo, B. W. Jr; more...
    Seminars in Thoracic and Cardiovascular Surgery (2025)

    Fulltext@MSK | Save
  • Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: A pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials
    Journal Article

    Williams, H.; Fokas, E.; Diefenhardt, M.; Lee, C.; Verheij, F. S.; Omer, D. M.; Lin, S. T.; Dunne, R. F.; Marcet, J.; Cataldo, P.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Biomarker analyses from the phase III randomized CLEAR trial: Lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Porta, C.; Eto, M.; Hutson, T. E.; Rha, S. Y.; Merchan, J. R.; Winquist, E.; Gurney, H.; Grünwald, V.; George, S.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • A plain language summary of the results from the MAGNITUDE study assessing how effective and how safe niraparib and abiraterone acetate with prednisone is in patients with metastatic castration-resistant prostate cancer
    Editorial

    Chi, K. N.; Rathkopf, D.; Smith, M. R.; Efstathiou, E.; Attard, G.; Olmos, D.; Lee, J. Y.; Small, E. J.; Pereira de Santana Gomes, A. J.; Roubaud, G.; more...
    Future Oncology (2025)

    Fulltext@MSK | Save
  • Clinical outcomes associated with anti-CD38-based retreatment in relapsed/refractory multiple myeloma: A systematic literature review
    Review

    Gay, F.; Zamagni, E.; Cole, C. E.; Scheid, C.; Hultcrantz, M.; Chorazy, J.; Iheanacho, I.; Pandey, A.; Bitetti, J.; Boytsov, N.; more...
    Frontiers in Oncology (2025)

    Fulltext@MSK | Save
  • Randomised controlled trial of a psychosocial digital health application to promote coping for caregivers of patients undergoing haematopoietic stem cell transplantation: A study protocol for the BMT-CARE app
    Journal Article

    Willis, K. D.; Barata, A.; Freese, M.; Applebaum, A. J.; Nelson, A.; Traeger, L. N.; Horick, N. K.; Rabideau, D. J.; Temel, J. S.; Greer, J. A.; more...
    BMJ Open (2025)

    Fulltext@MSK | Save
  • Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: ASCO guideline update
    Guidelines

    Gaillard, S.; Lacchetti, C.; Armstrong, D. K.; Cliby, W. A.; Edelson, M. I.; Garcia, A. A.; Ghebre, R. G.; Gressel, G. M.; Lesnock, J. L.; Meyer, L. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Communication interventions targeting both patients and clinicians in oncology: A systematic review of randomized controlled trials
    Review

    McDarby, M.; Mroz, E.; Walsh, L. E.; Malling, C.; Chilov, M.; Rosa, W. E.; Kastrinos, A.; McConnell, K. M.; Parker, P. A.
    Psycho-Oncology (2025)

    Fulltext@MSK | Save
  • Comparative efficacy and safety of ablative therapies in the management of primary localised renal cell carcinoma: A systematic review and meta-analysis
    Review

    Huang, R. S.; Chow, R.; Benour, A.; Chen, D.; Boldt, G.; Wallis, C. J. D.; Swaminath, A.; Simone, C. B. 2nd; Lock, M.; Raman, S.
    Lancet Oncology (2025)

    Fulltext@MSK | Save